Shelley B. Thunen
Chief Financial Officer, INTRALASE CORP.
Companies
- RxSight, Inc.Officer Jul 16, 2024 to now1
- LENZ Therapeutics, Inc.Board member Mar 25, 2024 to now2
- AEON Biopharma, Inc.Board member Jul 24, 2023 to now3
- RxSight, Inc.Chief financial officer Jul 29, 2021 to Jul 2, 20244
- Venus Concept Inc.Board member Oct 11, 2017 to Jun 15, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- RxSight, Inc. RXST38,354 shares6$181.0K at $4.72Apr 14, 2025
- AEON Biopharma, Inc. AEON258,705 shares7$61.2K at $0.24Jun 17, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 17, 2026Granted 222,684 shares of AEON Biopharma, Inc.7
- Apr 14, 2025Exercised options 7,792 shares at $4.34 of RxSight, Inc.6
- Oct 1, 2024Sold 278 shares at $49.45 of RxSight, Inc.8
- Oct 1, 2024Sold 9,521 shares at $48.69 of RxSight, Inc.8
- Oct 1, 2024Sold 5,201 shares at $47.96 of RxSight, Inc.8
- Oct 1, 2024Exercised options 15,000 shares at $16.00 of RxSight, Inc.8
- Aug 31, 2024Granted 36,021 shares of AEON Biopharma, Inc.9
- Jul 15, 2024Exercised options 16,505 shares at $4.34 of RxSight, Inc.10
- Jul 1, 2024Sold 1,803 shares at $59.56 of RxSight, Inc.11
- Jul 1, 2024Sold 6,599 shares at $58.55 of RxSight, Inc.11
- Jul 1, 2024Sold 1,854 shares at $59.48 of RxSight, Inc.11
- Jul 1, 2024Sold 8,146 shares at $58.41 of RxSight, Inc.11
- Jul 1, 2024Exercised options 10,000 shares at $15.60 of RxSight, Inc.11
- May 1, 2024Sold 380 shares at $53.04 of RxSight, Inc.12
- May 1, 2024Sold 9,620 shares at $52.68 of RxSight, Inc.12
- May 1, 2024Exercised options 10,247 shares at $15.60 of RxSight, Inc.12
- Apr 1, 2024Sold 543 shares at $51.50 of RxSight, Inc.13
- Apr 1, 2024Sold 200 shares at $50.37 of RxSight, Inc.13
- Apr 1, 2024Sold 662 shares at $50.24 of RxSight, Inc.13
- Apr 1, 2024Sold 8,938 shares at $49.81 of RxSight, Inc.13
- Apr 1, 2024Sold 800 shares at $50.27 of RxSight, Inc.13
- Apr 1, 2024Sold 8,857 shares at $49.81 of RxSight, Inc.13
- Mar 1, 2024Sold 2,473 shares at $57.03 of RxSight, Inc.14
- Mar 1, 2024Sold 6,361 shares at $56.38 of RxSight, Inc.14
- Mar 1, 2024Sold 1,166 shares at $54.95 of RxSight, Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRxSight, Inc., Officer
- 2
- 3SEC EDGARAEON Biopharma, Inc., Board member
- 4
- 5SEC EDGARVenus Concept Inc., Board member
- 6
- 7
- 8SEC EDGARForm 4 filed Oct 2, 2024
- 9SEC EDGARForm 4 filed Sep 4, 2024
- 10SEC EDGARForm 4 filed Jul 16, 2024
- 11SEC EDGARForm 4 filed Jul 2, 2024
- 12SEC EDGARForm 4 filed May 2, 2024
- 13SEC EDGARForm 4 filed Apr 2, 2024
- 14SEC EDGARForm 4 filed Mar 5, 2024